APO RESEARCH · REPORT
Natural Killer Cell Therapy
Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.
Product & engineering
Understand the product.
Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.
Selected research
Market Structure
Global Natural Killer Cell Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.
The Americas natural killer cells therapeutics market share accounted for the highest share 52.3% in 2019.
Based on application, the market is classified into cancer, gastrointestinal diseases and others. The cancer segment accounted for a major share in 2019 (66.99%).
Read the full market overview
Major players operating in the market include Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics and etc. The Top 6 players accounted for 96.66% of the global revenue market share in 2019.
Report Includes
This report provides an overview of the global Natural Killer Cell Therapy market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Natural Killer Cell Therapy and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Natural Killer Cell Therapy revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Natural Killer Cell Therapy market size, projected growth trends, production technologies, key applications, and end-use industries.
Natural Killer Cell Therapy Segment by Company
Nektar Therapeutics
Innate Pharma SA
Affimed
Chipscreen Biosciences
Glycostem Therapeutics
Fate Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
Nkarta Therapeutics
NantKwest
Natural Killer Cell Therapy Segment by Type
NK Cell Therapies
NK Cell Directed Antibodies
Natural Killer Cell Therapy Segment by Application
Cancer
Gastrointestinal Diseases
Others
Natural Killer Cell Therapy Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Natural Killer Cell Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Natural Killer Cell Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Natural Killer Cell Therapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Natural Killer Cell Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Natural Killer Cell Therapy industry.
Chapter 3: Detailed analysis of Natural Killer Cell Therapy companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Natural Killer Cell Therapyrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- NK Cell Therapies
- NK Cell Directed Antibodies
Applications
- Cancer
- Gastrointestinal Diseases
- Others
Companies covered
- Nektar Therapeutics
- Innate Pharma SA
- Affimed
- Chipscreen Biosciences
- Glycostem Therapeutics
- Fate Therapeutics
- Dragonfly Therapeutics
- Kiadis Pharma
- Nkarta Therapeutics
- NantKwest
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Natural Killer Cell Therapy Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 NK Cell Therapies
- 1.2.3 NK Cell Directed Antibodies
- 1.3 Market Analysis by Application
- 1.3.1 Global Natural Killer Cell Therapy Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Cancer
- 1.3.3 Gastrointestinal Diseases
- 1.3.4 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Natural Killer Cell Therapy Growth Trends by Region
- 1.5.1 Global Natural Killer Cell Therapy Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Natural Killer Cell Therapy Market Size by Region (2021-2026)
- 1.5.3 Natural Killer Cell Therapy Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Natural Killer Cell Therapy Market Dynamics
- 2.1 Natural Killer Cell Therapy Industry Trends
- 2.2 Natural Killer Cell Therapy Industry Drivers
- 2.3 Natural Killer Cell Therapy Industry Opportunities and Challenges
- 2.4 Natural Killer Cell Therapy Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Natural Killer Cell Therapy Revenue by Company (2021-2026)
- 3.2 Global Natural Killer Cell Therapy Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Natural Killer Cell Therapy Key Company Head office and Area Served
- 3.4 Global Natural Killer Cell Therapy Company, Product Type & Application
- 3.5 Global Natural Killer Cell Therapy Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Natural Killer Cell Therapy Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Natural Killer Cell Therapy Players Market Share by Revenue in 2025
- 3.6.3 2025 Natural Killer Cell Therapy Tier 1, Tier 2, and Tier 3
4 Natural Killer Cell Therapy Market by Type
- 4.1 Global Natural Killer Cell Therapy Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Natural Killer Cell Therapy Market Size by Type (2021-2032)
- 4.3 Global Natural Killer Cell Therapy Market Size Share by Type (2021-2032)
5 Natural Killer Cell Therapy Market by Application
- 5.1 Global Natural Killer Cell Therapy Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Natural Killer Cell Therapy Market Size by Application (2021-2032)
- 5.3 Global Natural Killer Cell Therapy Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Nektar Therapeutics
- 6.1.1 Nektar Therapeutics Company Information
- 6.1.2 Nektar Therapeutics Business Overview
- 6.1.3 Nektar Therapeutics Natural Killer Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Nektar Therapeutics Natural Killer Cell Therapy Product Portfolio
- 6.1.5 Nektar Therapeutics Recent Developments
- 6.2 Innate Pharma SA
- 6.2.1 Innate Pharma SA Company Information
- 6.2.2 Innate Pharma SA Business Overview
- 6.2.3 Innate Pharma SA Natural Killer Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Innate Pharma SA Natural Killer Cell Therapy Product Portfolio
- 6.2.5 Innate Pharma SA Recent Developments
- 6.3 Affimed
- 6.3.1 Affimed Company Information
- 6.3.2 Affimed Business Overview
- 6.3.3 Affimed Natural Killer Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Affimed Natural Killer Cell Therapy Product Portfolio
- 6.3.5 Affimed Recent Developments
- 6.4 Chipscreen Biosciences
- 6.4.1 Chipscreen Biosciences Company Information
- 6.4.2 Chipscreen Biosciences Business Overview
- 6.4.3 Chipscreen Biosciences Natural Killer Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Chipscreen Biosciences Natural Killer Cell Therapy Product Portfolio
- 6.4.5 Chipscreen Biosciences Recent Developments
- 6.5 Glycostem Therapeutics
- 6.5.1 Glycostem Therapeutics Company Information
- 6.5.2 Glycostem Therapeutics Business Overview
- 6.5.3 Glycostem Therapeutics Natural Killer Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Glycostem Therapeutics Natural Killer Cell Therapy Product Portfolio
- 6.5.5 Glycostem Therapeutics Recent Developments
- 6.6 Fate Therapeutics
- 6.6.1 Fate Therapeutics Company Information
- 6.6.2 Fate Therapeutics Business Overview
- 6.6.3 Fate Therapeutics Natural Killer Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Fate Therapeutics Natural Killer Cell Therapy Product Portfolio
- 6.6.5 Fate Therapeutics Recent Developments
- 6.7 Dragonfly Therapeutics
- 6.7.1 Dragonfly Therapeutics Company Information
- 6.7.2 Dragonfly Therapeutics Business Overview
- 6.7.3 Dragonfly Therapeutics Natural Killer Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Dragonfly Therapeutics Natural Killer Cell Therapy Product Portfolio
- 6.7.5 Dragonfly Therapeutics Recent Developments
- 6.8 Kiadis Pharma
- 6.8.1 Kiadis Pharma Company Information
- 6.8.2 Kiadis Pharma Business Overview
- 6.8.3 Kiadis Pharma Natural Killer Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Kiadis Pharma Natural Killer Cell Therapy Product Portfolio
- 6.8.5 Kiadis Pharma Recent Developments
- 6.9 Nkarta Therapeutics
- 6.9.1 Nkarta Therapeutics Company Information
- 6.9.2 Nkarta Therapeutics Business Overview
- 6.9.3 Nkarta Therapeutics Natural Killer Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Nkarta Therapeutics Natural Killer Cell Therapy Product Portfolio
- 6.9.5 Nkarta Therapeutics Recent Developments
- 6.10 NantKwest
- 6.10.1 NantKwest Company Information
- 6.10.2 NantKwest Business Overview
- 6.10.3 NantKwest Natural Killer Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 NantKwest Natural Killer Cell Therapy Product Portfolio
- 6.10.5 NantKwest Recent Developments
7 North America
- 7.1 North America Natural Killer Cell Therapy Market Size (2021-2032)
- 7.2 North America Natural Killer Cell Therapy Market Size by Type
- 7.2.1 North America Natural Killer Cell Therapy Market Size by Type (2021-2026)
- 7.2.2 North America Natural Killer Cell Therapy Market Size by Type (2027-2032)
- 7.2.3 North America Natural Killer Cell Therapy Market Share by Type (2021-2032)
- 7.3 North America Natural Killer Cell Therapy Market Size by Application
- 7.3.1 North America Natural Killer Cell Therapy Market Size by Application (2021-2026)
- 7.3.2 North America Natural Killer Cell Therapy Market Size by Application (2027-2032)
- 7.3.3 North America Natural Killer Cell Therapy Market Share by Application (2021-2032)
- 7.4 North America Natural Killer Cell Therapy Market Size by Country
- 7.4.1 North America Natural Killer Cell Therapy Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Natural Killer Cell Therapy Market Size by Country (2021-2026)
- 7.4.3 North America Natural Killer Cell Therapy Market Size by Country (2027-2032)
- 7.4.4 North America Natural Killer Cell Therapy Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Natural Killer Cell Therapy Market Size (2021-2032)
- 8.2 Europe Natural Killer Cell Therapy Market Size by Type
- 8.2.1 Europe Natural Killer Cell Therapy Market Size by Type (2021-2026)
- 8.2.2 Europe Natural Killer Cell Therapy Market Size by Type (2027-2032)
- 8.2.3 Europe Natural Killer Cell Therapy Market Share by Type (2021-2032)
- 8.3 Europe Natural Killer Cell Therapy Market Size by Application
- 8.3.1 Europe Natural Killer Cell Therapy Market Size by Application (2021-2026)
- 8.3.2 Europe Natural Killer Cell Therapy Market Size by Application (2027-2032)
- 8.3.3 Europe Natural Killer Cell Therapy Market Share by Application (2021-2032)
- 8.4 Europe Natural Killer Cell Therapy Market Size by Country
- 8.4.1 Europe Natural Killer Cell Therapy Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Natural Killer Cell Therapy Market Size by Country (2021-2026)
- 8.4.3 Europe Natural Killer Cell Therapy Market Size by Country (2027-2032)
- 8.4.4 Europe Natural Killer Cell Therapy Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Natural Killer Cell Therapy Market Size (2021-2032)
- 9.2 China Natural Killer Cell Therapy Market Size by Type
- 9.2.1 China Natural Killer Cell Therapy Market Size by Type (2021-2026)
- 9.2.2 China Natural Killer Cell Therapy Market Size by Type (2027-2032)
- 9.2.3 China Natural Killer Cell Therapy Market Share by Type (2021-2032)
- 9.3 China Natural Killer Cell Therapy Market Size by Application
- 9.3.1 China Natural Killer Cell Therapy Market Size by Application (2021-2026)
- 9.3.2 China Natural Killer Cell Therapy Market Size by Application (2027-2032)
- 9.3.3 China Natural Killer Cell Therapy Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Natural Killer Cell Therapy Market Size (2021-2032)
- 10.2 Asia Natural Killer Cell Therapy Market Size by Type
- 10.2.1 Asia Natural Killer Cell Therapy Market Size by Type (2021-2026)
- 10.2.2 Asia Natural Killer Cell Therapy Market Size by Type (2027-2032)
- 10.2.3 Asia Natural Killer Cell Therapy Market Share by Type (2021-2032)
- 10.3 Asia Natural Killer Cell Therapy Market Size by Application
- 10.3.1 Asia Natural Killer Cell Therapy Market Size by Application (2021-2026)
- 10.3.2 Asia Natural Killer Cell Therapy Market Size by Application (2027-2032)
- 10.3.3 Asia Natural Killer Cell Therapy Market Share by Application (2021-2032)
- 10.4 Asia Natural Killer Cell Therapy Market Size by Country
- 10.4.1 Asia Natural Killer Cell Therapy Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Natural Killer Cell Therapy Market Size by Country (2021-2026)
- 10.4.3 Asia Natural Killer Cell Therapy Market Size by Country (2027-2032)
- 10.4.4 Asia Natural Killer Cell Therapy Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Natural Killer Cell Therapy Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Natural Killer Cell Therapy Market Size by Type
- 11.2.1 South America, Middle East & Africa Natural Killer Cell Therapy Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Natural Killer Cell Therapy Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Natural Killer Cell Therapy Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Natural Killer Cell Therapy Market Size by Application
- 11.3.1 South America, Middle East & Africa Natural Killer Cell Therapy Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Natural Killer Cell Therapy Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Natural Killer Cell Therapy Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Natural Killer Cell Therapy Market Size by Country
- 11.4.1 South America, Middle East & Africa Natural Killer Cell Therapy Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Natural Killer Cell Therapy Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Natural Killer Cell Therapy Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Natural Killer Cell Therapy Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst